HealthExec September 15, 2022
As Medicare Advantage (MA) eclipses more and more of the Medicare market, it is critical to understand how MA plans are able to save costs and provide quality care to recipients.
One recent study published in JAMA Network found MA has fewer instances of low-value care––such as tests, treatments and procedures that provide little to no clinical benefit––compared to traditional Medicare. The cross-sectional study of more than 2.4 million Medicare beneficiaries found that MA beneficiaries received 9.2% fewer low-value services compared to traditional Medicare beneficiaries in 2019.
In general, low-value care is a big money-waster across the healthcare industry, as well as a cause of inefficiency and even potential harm. As many as one-third of Medicare beneficiaries receive low-value...